A Clinical Study of Treating Influenza With Liugan Shuangjie Heji
Status:
Unknown status
Trial end date:
2016-11-01
Target enrollment:
Participant gender:
Summary
This prospective randomized controlled trial studies the efficacy and safety of treating
influenza with the reconciling exterior and interior therapy. A total of 300 cases of
seasonal flu in Beijing is to be collected, and divided into one treatment group and two
control groups. Patients in the treatment group will receive Liugan Shuangjie Heji, while
patients in control groups will receive Shufeng Jiedu Capsule and Oseltamivir Phosphate
Capsule respectively, for a course of 5 days. The study assesses the efficacy and safety of
treating influenza with the reconciling therapy based on the following outcome measures: the
time it takes from the medicine intake to 0.5℃ drop of body temperature, and the time it
takes for the body temperature to return to normal.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Dongfang Hospital Affiliated to Beijing University of Chinese Medicine Dongfang Hospital Beijing University of Chinese Medicine